| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.318 | 179.513 | 170.644 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.318 | 180.139 | 170.353 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 599 | 162.557 | 177.574 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 719 | 17.582 | -7.222 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 705 | 16.038 | -11.352 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
Check the financial reports for the company - Isrom Science S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.145 | 1.133 | 1.114 | 1.094 | 1.073 | 1.052 | 1.029 | 1.032 | 6.746 | 5.792 |
| Current Assets | 1.576 | 1.560 | 1.534 | 1.506 | 1.477 | 1.449 | 1.416 | 9.303 | 40.239 | 67.756 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 558 | 1.380 | 1.477 |
| Receivables | 1.518 | 1.502 | 1.477 | 1.450 | 1.422 | 1.395 | 1.364 | 1.473 | 14.607 | 51.609 |
| Cash | 59 | 58 | 57 | 56 | 55 | 54 | 53 | 7.272 | 24.252 | 14.670 |
| Shareholders Funds | 2.061 | 2.040 | 2.005 | 1.968 | 1.930 | 1.893 | 1.851 | 2.563 | 18.593 | 7.137 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 661 | 654 | 643 | 631 | 619 | 607 | 594 | 7.772 | 28.392 | 66.411 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Isrom Science S.r.l.